scholarly journals Intensive Rehabilitation Therapy Following Brain Tumor Surgery: A Pilot Study of Effectiveness and Long-Term Satisfaction

2019 ◽  
Vol 43 (2) ◽  
pp. 129-141 ◽  
Author(s):  
Junghoon Yu ◽  
Youngsu Jung ◽  
Joonhyun Park ◽  
Jong Moon Kim ◽  
Miri Suh ◽  
...  
Keyword(s):  
Brain Tumor ◽  
Pilot Study ◽  
Tumor Surgery ◽  
Brain Tumor Surgery ◽  
Rehabilitation Therapy ◽  
Intensive Rehabilitation

scholarly journals Effectiveness of perioperative antiepileptic drug prophylaxis for early and late seizures following oncologic neurosurgery: a meta-analysis

2019 ◽  
Vol 130 (4) ◽  
pp. 1274-1282 ◽  
Author(s):  
Evan F. Joiner ◽  
Brett E. Youngerman ◽  
Taylor S. Hudson ◽  
Jingyan Yang ◽  
Mary R. Welch ◽  
...  
Keyword(s):  
Brain Tumor ◽  
Antiepileptic Drug ◽  
Meta Analysis ◽  
Risk Of Bias ◽  
Controlled Trials ◽  
Tumor Surgery ◽  
Brain Tumor Surgery ◽  
Short And Long Term ◽  
Early Seizures

OBJECTIVEThe purpose of this meta-analysis was to evaluate the impact of perioperative antiepileptic drug (AED) prophylaxis on short- and long-term seizure incidence among patients undergoing brain tumor surgery. It is the first meta-analysis to focus exclusively on perioperative AED prophylaxis among patients undergoing brain tumor surgery.METHODSThe authors searched PubMed/MEDLINE, Embase, Cochrane Central Register of Controlled Trials, clinicaltrials.gov, and the System for Information on Gray Literature in Europe for records related to perioperative AED prophylaxis for patients with brain tumors. Risk of bias in the included studies was assessed using the Cochrane risk of bias tool. Incidence rates for early seizures (within the first postoperative week) and total seizures were estimated based on data from randomized controlled trials. A Mantel-Haenszel random-effects model was used to analyze pooled relative risk (RR) of early seizures (within the first postoperative week) and total seizures associated with perioperative AED prophylaxis versus control.RESULTSFour RCTs involving 352 patients met the criteria of inclusion. The results demonstrated that perioperative AED prophylaxis for patients undergoing brain tumor surgery provides a statistically significant reduction in risk of early postoperative seizures compared with control (RR = 0.352, 95% confidence interval 0.130–0.949, p = 0.039). AED prophylaxis had no statistically significant effect on the total (combined short- and long-term) incidence of seizures.CONCLUSIONSThis meta-analysis demonstrates for the first time that perioperative AED prophylaxis for brain tumor surgery provides a statistically significant reduction in early postoperative seizure risk.

Early systemic complications after brain tumor surgery: Comparison between early awakening or long-term sedation

2008 ◽  
Vol 25 (Sup 44) ◽  
pp. 98
Author(s):  
K. Vaninbrouckx ◽  
C. De Deyne ◽  
M. Vanderlaenen ◽  
F. Weyns ◽  
R. Heylen
Keyword(s):  
Brain Tumor ◽  
Tumor Surgery ◽  
Brain Tumor Surgery ◽  
Systemic Complications

scholarly journals Long-term Risk of Shunt Failure After Brain Tumor Surgery

2021 ◽  
Author(s):  
Sayied Abdol Mohieb Hosainey ◽  
Benjamin Lassen Lykkedrang ◽  
Torstein R Meling
Keyword(s):  
Brain Tumor ◽  
Significant Risk ◽  
Tumor Surgery ◽  
Shunt Failure ◽  
Survival Times ◽  
Brain Tumor Surgery ◽  
Shunt Insertion ◽  
Vp Shunt ◽  
Shunt Survival

Abstract Long-term risks and survival times of ventriculoperitoneal (VP) shunts implanted due to hydrocephalus (HC) after craniotomy for brain tumors are largely unknown. The aim of this study was to establish the overall VP shunt survival rates during a decade post-shunt insertion and to determine risks of failure after brain tumor surgery in the long-term period. In this population-based cohort from a well-defined geographical region, all adult patients (> 18 years) from 2004-2013 who underwent craniotomies for intracranial tumors leading to VP shunt dependency were included. Our brain tumor database was cross-linked to procedure codes for shunt surgery (codes AAF) to extract brain tumor patients who became VP shunt dependent after craniotomy. The VP shunt survival times, i.e. the shunt longevity, was calculated from the day of shunt insertion after brain tumor surgery until the day of its failure. A total of 4174 patients underwent craniotomies, of whom 85 became VP shunt-dependent (2%) afterwards. Twenty-eight patients (33%) had one or more shunt failures during their long-term follow-up, yielding 1-, 5- and 10-year shunt success rates of 77%, 71%, and 67%, respectively. Patient age, sex, tumor location, primary/repeat craniotomy, ventricular entry, post-craniotomy hemorrhage, post-shunting meningitis/infection and multiple shunt revisions were not statistically significant risk factors for shunt failure. Median shunt longevity was 457.5 days and 21.5 days for those with and without pre-craniotomy HC, respectively (p < 0.01). This study can serve as benchmark for future studies.

Machine Learning Algorithm to Predict Early Complications after Brain Tumor Surgery

2018 ◽  
Author(s):  
C.H.B. van Niftrik ◽  
F. van der Wouden ◽  
V. Staartjes ◽  
J. Fierstra ◽  
M. Stienen ◽  
...  
Keyword(s):  
Machine Learning ◽  
Brain Tumor ◽  
Learning Algorithm ◽  
Machine Learning Algorithm ◽  
Tumor Surgery ◽  
Early Complications ◽  
Brain Tumor Surgery

Role of Perioperative Factor XIII in Intracerebral Hemorrhage after Brain Tumor Surgery: A Prospective Study

2019 ◽  
Author(s):  
Estela Val Jordan ◽  
Agustín Nebra Puertas ◽  
Juan Casado Pellejero ◽  
Maria Dolores Vicente Gordo ◽  
Concepción Revilla López ◽  
...  
Keyword(s):  
Brain Tumor ◽  
Intracerebral Hemorrhage ◽  
Prospective Study ◽  
Factor Xiii ◽  
Tumor Surgery ◽  
Brain Tumor Surgery ◽  
A Prospective Study

Virtual Reality during Brain Mapping for Awake-Patient Brain Tumor Surgery: Proposed Tasks and Domains to Test

2021 ◽  
Author(s):  
Gennadiy A. Katsevman ◽  
Walter Greenleaf ◽  
Ricardo García-García ◽  
Maria Victoria Perea ◽  
Valentina Ladera ◽  
...  
Keyword(s):  
Virtual Reality ◽  
Brain Tumor ◽  
Brain Mapping ◽  
Tumor Surgery ◽  
Awake Patient ◽  
Brain Tumor Surgery

scholarly journals MS-1 Surgical strategy for brain tumor based on molecular and functional connectomics profiles

2020 ◽  
Vol 2 (Supplement_3) ◽  
pp. ii2-ii2
Author(s):  
Tatsuya Abe
Keyword(s):  
Overall Survival ◽  
Brain Tumor ◽  
Standard Procedure ◽  
Awake Craniotomy ◽  
Surgical Strategy ◽  
Neurological Deficits ◽  
Cortical Mapping ◽  
Photodynamic Diagnosis ◽  
Tumor Surgery ◽  
Brain Tumor Surgery

Abstract It is reported that the development of new perioperative motor deficits was associated with decreased overall survival despite similar extent of resection and adjuvant therapy. The maximum safe resection without any neurological deficits is required to improve overall survival in patients with brain tumor. Surgery is performed with various modalities, such as neuro-monitoring, photodynamic diagnosis, neuro-navigation, awake craniotomy, intraoperative MRI, and so on. Above all, awake craniotomy technique is now the standard procedure to achieve the maximum safe resection in patients with brain tumor. It is well known that before any treatment, gliomas generate globally (and not only focally) altered functional connectomics profiles, with various patterns of neural reorganization allowing different levels of cognitive compensation. Therefore, perioperative cortical mapping and elucidation of functional network, neuroplasticity and reorganization are important for brain tumor surgery. On the other hand, recent studies have proposed several gene signatures as biomarkers for different grades of gliomas from various perspectives. Then, we aimed to identify these biomarkers in pre-operative and/or intra-operative periods, using liquid biopsy, immunostaining and various PCR methods including rapid genotyping assay. In this presentation, we would like to demonstrate our surgical strategy based on molecular and functional connectomics profiles.

Clinical outcome assessments of motor status in patients undergoing brain tumor surgery

2021 ◽  
Vol 201 ◽  
pp. 106420
Author(s):  
Mayla Santana Correia ◽  
Iuri Santana Neville ◽  
Cesar Cimonari de Almeida ◽  
Cintya Yukie Hayashi ◽  
Luana Talita Diniz Ferreira ◽  
...  
Keyword(s):  
Brain Tumor ◽  
Clinical Outcome ◽  
Tumor Surgery ◽  
Brain Tumor Surgery ◽  
Outcome Assessments ◽  
Clinical Outcome Assessments
Sign in / Sign up

Export Citation Format

Share Document